GDNF and schizophrenia: As mentioned above, most studies of GDNF/GFRA1 signaling are related to neurodegenerative (Parkinson’s disease and Alzheimer’s disease) and neuropsychiatric diseases (addiction, bipolar disorder, obsessive compulsive disorder, depression, anxiety, autism, schizophrenia, and attention deficit hyperactivity disorder).